• Protocols

• AALL1732

  OPEN TO ACCRUAL

  Phase 3 Inotuzumab Ozogamicin for Newly Dx HR B ALL plus MPAL and Disseminated B LLy
  
  

• APEC14B1

  OPEN TO ACCRUAL

  Project: Every Child A Registry, Eligibility Screening, Biology and Outcome Study